American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee

Arthritis Care and Research

Volumn 64, Issue 4, 2012, Pages 465-474

  Hochberg, Marc C ^a   Altman, Roy D ^b   April, Karine Toupin ^c   Benkhalti, Maria ^d   Guyatt, Gordon ^d   McGowan, Jessie ^c   Towheed, Tanveer ^e   Welch, Vivian ^c   Wells, George ^c   Tugwell, Peter ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CHONDROITIN SULFATE; CORTICOSTEROID; DULOXETINE; GLUCOSAMINE; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; TRAMADOL;

AEROBIC EXERCISE; AQUATIC EXERCISE; ARTHROPLASTY; ARTICLE; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; HAND OSTEOARTHRITIS; HIP OSTEOARTHRITIS; HUMAN; KINESIOTHERAPY; KNEE OSTEOARTHRITIS; MANIPULATIVE MEDICINE; MEDICAL SOCIETY; OSTEOARTHRITIS; PRACTICE GUIDELINE; RESISTANCE TRAINING; SELF CARE; SPLINT; TAI CHI; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT REFUSAL; VALGUS KNEE; WALKING AID; WEIGHT REDUCTION; CONFERENCE PAPER; HAND JOINT; UNITED STATES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HAND JOINTS; HUMANS; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PRACTICE GUIDELINES AS TOPIC; RESISTANCE TRAINING; SOCIETIES, MEDICAL; TRAMADOL; UNITED STATES; WEIGHT LOSS;

EID: 84859773681     PISSN: 00043591     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21596     Document Type: Article

References (46)

1. Dougados M, Hochberg MC. Management of osteoarthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman M, editors. Rheumatology. 5th ed. Philadelphia: Mosby/ Elsevier; 2011. p. 1793-9.
2. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15.
3. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. 2005. URL: http://www.rheumatology.org/practice/clinical/ guidelines/oa-mgmt.asp.
4. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55. (Pubitemid 37500619)
5. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2005;64:669-81. (Pubitemid 40559291)
6. Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2007;66:377-88. (Pubitemid 46579641)
7. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16: 137-62. (Pubitemid 351222155)
8. American Academy of Orthopaedic Surgeons. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis of the knee (non-arthroplasty). Rosemont (IL): American Academy of Orthopaedic Surgeons; 2008.
9. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84. (Pubitemid 351847559)
10. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
11. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. (Pubitemid 351632017)
12. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ, for the GRADE Working Group. What is "quality of evidence" and why is it important to clinicians? BMJ 2008;336:995-8. (Pubitemid 351656090)
13. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to recommendations. BMJ 2008;336:1049-51.
14. GRADE Working Group. Organizations that have endorsed or that are using GRADE. URL: http://www.gradeworkinggroup.org/society/index.htm.
15. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ 2005;330:1179.
16. Montori VM, Wilczynski NL, Morgan D, Haynes RB. Optimal search strategies for retrieving systematic reviews from Medline: analytical survey. BMJ 2005;330:68.
17. Wilczynski NL, Haynes RB, for the Hedges Team. Embase search strategies achieved high sensitivity and specificity for retrieving methodologically sound systematic reviews. J Clin Epidemiol 2007;60:29-33. (Pubitemid 44856234)
18. American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum 2008;59: 1058-73.
19. Chou R, Helfand M, Peterson K, Dana T, Roberts C. Comparative effectiveness and safety of analgesics for osteoarthritis: comparative effectiveness review no. 4. Rockville (MD): Agency for Healthcare Research and Quality; 2006. URL: www.effectivehealthcare.ahrq.gov/reports/final.cfm.
20. Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N. Treatment of primary and secondary osteoarthritis of the knee: evidence report/technology assessment no. 157. AHRQ publication no. 07-E012. Rockville (MD): Agency for Healthcare Research and Quality; 2007.
21. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians. A scientific statement from the American Heart Association. Circulation 2007;115:1634-42. (Pubitemid 46648649)
22. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2008;52:1502-17.
23. Jaeschke R, Guyatt GH, Dellinger P, Schunemann H, Levy MM, Kunz R, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008;337:a744.
24. Mahendira D, Towheed TE. Systematic review of non-surgical therapies for osteoarthritis of the hand: an update. Osteoarthritis Cartilage 2009;17:1263-8.
25. Fransen M, McConnell S. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev 2008;4:CD004376.
26. Fransen M, McConnell S, Hernandez-Molina G, Reichenbach S. Does land-based exercise reduce pain and disability associated with hip osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2010;18:613-20.
27. Christensen R, Bartels EM, Astrup A, Bliddal H. Effect of weight reduction in obese patients with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2007; 66:433-9. (Pubitemid 46580460)
28. American Geriatrics Society Panel of the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57:1331-46.
29. Rostom A, Muir K, Dube C, Lanas A, Jolicoeur E, Tugwell P. Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf 2009;1:47-71.
30. Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG, et al. Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. BMJ 2009;339:b2538.
31. Ellison J, Dager W. Recent FDA warning of the concomitant use of aspirin and ibuprofen and the effects on platelet aggregation. Prev Cardiol 2007;10:61-3.
32. US Food and Drug Administration. Information for healthcare professionals: concomitant use of ibuprofen and aspirin. 2006. URL: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm125222.htm.
33. Schuijt MP, Huntjens-Fleuren HW, de Metz M, Vollaard EJ. The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers. Br J Pharmacol 2009;157:931-4.
34. Wilner KD, Rushing M, Walden C, Adler R, Eskra J, Noveck R, et al. Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers. J Clin Pharmacol 2002;42:1027-30. (Pubitemid 34920801)
35. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30.
36. Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 2009;64:669-77.
37. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007;15:981-1000. (Pubitemid 47393443)
38. Hochberg MC. Quality measures in osteoarthritis. Clin Exp Rheumatol 2007;25 Suppl:61-5.
39. Hunter DJ, Neogi T, Hochberg MC. Quality of osteoarthritis management and the need for reform in the US. Arthritis Care Res (Hoboken) 2011;63:31-8.
40. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808. (Pubitemid 43290918)
41. Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005;2:CD002946.
42. Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum 2007;56:2267-77. (Pubitemid 47173575)
43. Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007;146:580-90. (Pubitemid 351650539)
44. Wandel S, Juni P, Tendal B, Nuesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010;341:c4675.
45. Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther 2009;11:227.
46. Felson DT. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009;11:203.